Replies to post #14197 on US Stem Cell Inc (USRM)

[BluSkies]

I am sure it has to do with those other 3 potential partnerships on the table. We don't know who ended the contract, was Global or BHRT? Maybe there is another deal on the table that wants exclusivity I am thinking. With all these BHRT technologies, someone could be rich over night if this was FDA approved- in my opinion.

[Investaholic33]

I don't think this can be looked at negatively. 'Losing' Global Stem Cell Group as a partner just means that we're not splitting our revenues with anyone else. This happened in November. Since then, we've had an excellent shareholder presentation specifically outlining Bioheart's own sales force initiatives, appointed a world-renowned executive as the president of VetBiologics, and stated the possibility of a share buy-back.
If they know what they're doing, then why split the revenue with anyone else?

More money for Bioheart and more control over their operations.